KAYLEE RETSECK: Open Payments
NPI 1811623317 · SULLIVAN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 21 payments from 5 companies in 2025. Trend: 2023 $1,042 · 2024 $597 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $270 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| Teva Pharmaceuticals USA, Inc. | 2 | $64 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: CAPLYTA, REXULTI, UZEDY, FANAPT, COBENFY.
Industry payments across IN — which companies pay providers there.
